Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Association of Clinical Research Organizations (ACRO) Welcomes Two New Member Companies

By Pharmaceutical Processing | September 2, 2008

The Association of Clinical Research Organizations (ACRO), which represents the clinical research organization (CRO) industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, today announced the addition of two new member companies to the association as well as the appointment of a new representative to the ACRO Board of Directors. Clinilabs, Inc., a specialty CRO that provides a full portfolio of services focused on the development of central nervous system and cardiovascular therapeutics, has joined ACRO as an associate member. ReSearch Pharmaceutical Services, Inc. (RPS), a leading provider of comprehensive global Phase I-IV clinical development solutions, has joined at the regular member level. In addition, Daniel M. Perlman, Chairman and CEO of RPS, has been named to the ACRO Board of Directors. All regular members of ACRO are represented with a seat on the association’s Board. “I am extremely pleased to welcome Clinilabs and RPS as new members of ACRO,” said David Spaight, ACRO Chair and President of MDS Pharma Services. “Their involvement will enhance the association’s ability to represent the CRO industry broadly to government officials, research sponsors, patient groups, and others international stakeholders. We invite all CROs to consider membership in our industry’s trade association.”“The association looks forward to the addition of Mr. Perlman to our Board of Directors,” added ACRO Executive Director Doug Peddicord, Ph.D. “The leadership and vision of the ACRO Board is instrumental in driving our efforts to advance the CRO industry and to promote CROs as strategic partners in drug development.”

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE